Taltz (ixekizumab) is a prescription drug that’s used to treat certain autoimmune conditions such as psoriasis. Taltz’s cost may depend on factors such as your dosage, whether you have health ...

It’s not known whether Taltz (ixekizumab) is safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. If you may be or can ...

TALTZ is classified as a small molecule drug and is produced using recombinant DNA technology in a mammalian cell line. It is approved for use in patients aged six and older with moderate-to ...

Eli Lilly’s Taltz has beaten AbbVie’s blockbuster Humira in a psoriatic arthritis study involving patients who hadn’t been treated before with a disease-modifying drug, but only just.

respectively. Meanwhile, the autoimmune drug Taltz saw revenue rise 21% to $952 million. Source: Eli Lilly.

The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is ...

Meanwhile, the autoimmune drug Taltz saw revenue rise 21% to $952 million. Lilly's U.S. revenue jumped 40% to $9 billion, while international revenue climbed 55% to $4.5 billion. Gross margins ...